These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36199550)

  • 1. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.
    Xue H; Wang Y; Xiang H; Song Q; Zhang G; Wang J; Ge S
    Evid Based Complement Alternat Med; 2022; 2022():5440347. PubMed ID: 36199550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking.
    Luo Z; Xia LY; Tang YQ; Huang L; Liu D; Huai WY; Zhang CJ; Wang YQ; Xie YM; Yin QZ; Chen YH; Zhang TE
    Evid Based Complement Alternat Med; 2022; 2022():1670014. PubMed ID: 35096103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
    Li S; Wu X; Ma Y; Zhang H; Chen W
    J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the Effect and Mechanism of Huaji Jianpi Decoction on Simple Obesity.
    Zhu M; Zhang B; Zhang J; Ge S; Liu M
    Evid Based Complement Alternat Med; 2022; 2022():5494224. PubMed ID: 35529938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.
    Xu Z; Lin S; Gong J; Feng P; Cao Y; Li Q; Jiang Y; You Y; Tong Y; Wang P
    Front Med (Lausanne); 2021; 8():681391. PubMed ID: 34179049
    [No Abstract]   [Full Text] [Related]  

  • 9. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
    Yang H; Wei D; Zhang Y; Jian W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
    Wei S; Li J; Han DW; Fu Q; Hao F
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
    Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
    Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease.
    Yang R; Jiang D; Xu H; Yang H; Feng L; Wu Q; Xing Y
    Curr Comput Aided Drug Des; 2024 Jul; ():. PubMed ID: 38994616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology.
    Li Y; Liu Y; Yang M; Wang Q; Zheng Y; Xu J; Zheng P; Song H
    Evid Based Complement Alternat Med; 2021; 2021():8819245. PubMed ID: 33505505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation
    Yin G; Liang H; Sun W; Zhang S; Feng Y; Liang P; Chen S; Liu X; Pan W; Zhang F
    Front Pharmacol; 2022; 13():1016745. PubMed ID: 36506575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and
    Lei S; Zhao S; Huang X; Feng Y; Li Z; Chen L; Huang P; Guan H; Zhang H; Wu Q; Chen B
    Front Pharmacol; 2022; 13():967623. PubMed ID: 36172180
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
    Wu Z; Ji X; Shan C; Song J; Zhao J
    Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of Triclosan in the Treatment of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology].
    Zuo C; Sun DL; Zhao TH; Wang JJ; Zhang ZZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):253-261. PubMed ID: 35538760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury.
    Ma C; Zhao M; Du Y; Jin S; Wu X; Zou H; Zhang Q; Gao L
    Evid Based Complement Alternat Med; 2021; 2021():6661667. PubMed ID: 33747110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the protective mechanism of baicalin in treatment of fatty liver based on network pharmacology and cell model of NAFLD.
    Wen Y; Yi F; Zhang J; Wang Y; Zhao C; Zhao B; Wang J
    Int Immunopharmacol; 2024 Nov; 141():112954. PubMed ID: 39153306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.